1. 2551 GnRH antagonist plus bicalutamide may be an effective therapy as initial combined androgen blockade for patients with high grade prostate cancer. (September 2015) Authors: Uemura, M.; Nagahara, A.; Yamamoto, Y.; Takada, S.; Inagaki, Y.; Kinouchi, T.; Miyake, O.; Nakazawa, S.; Nishimura, K.; Arai, H.; Honda, M.; Okada, K.; Tsujihata, M.; Tsutahara, K.; Yamaguchi, S.; Kawashima, A.; Ujike, T.; Fujita, K.; Nonomura, N. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗